We have prepared '251-labeled physalaemin and have examined the kinetics, stoichiometry, and chemical specificity with which the labeled peptide binds to dispersed acini from guinea pig pancreas. Binding of '25I-labeled physalaemin was saturable, temperature-ependent, and reversible and reflected interaction of the labeled peptide with We (1, 2) and others (3, 4) have found that peptides isolated from amphibian skin (caerulein, bombesin, litorin, and physalaemin) as well as eledoisin, a peptide isolated from the salivary gland of a Mediterranean octopod,t produce changes in the function of pancreatic acinar cells similar to those caused by muscarinic cholinergic agents and cholecystokinin (CCK). In pancreatic fragments as well as dispersed acinar cells, each of these amphibian peptides increases amylase secretion, cellular cyclic GMP, and outflux of exchangeable cellular calcium but does not alter cellular cyclic AMP (1). These effects of amphibian peptides are not inhibited by atropine (1, 4), and therefore are not mediated by muscarinic cholinergic receptors. The effects of caerulein appear to be mediated by receptors that also interact with CCK because the actions of caerulein and CCK, but not those of other pancreatic secretagogues, can be inhibited competitively by dibutyryl cyclic GMP (5). The effects of bombesin and litorin on pancreatic acinar cells appear to be mediated by a common receptor that does not interact with other secretagogues. Binding of 125I-labeled [Tyr4] bombesin (125I-[Tyr4]bombesin) to pancreatic acini in vitro can be inhibited by bombesin and litorin but not by other secretagogues (6) and there is a close correlation between the abilities of bombesin and litorin to inhibit binding of 1251-[Tyr4]bombesin and their abilities to alter the function of pancreatic acini (6). Because physalaemin and eledoisin have similar COOHterminal amino acid sequences and do not interact with receptors for other pancreatic secretagogues, we have proposed (1) that these peptides might interact with a common class of receptors.To explore further the interaction of physalaemin and structurally similar peptides with pancreatic acini, we have prepared 125I-labeled physalaemin (125I-physalaemin) and have examined its ability to bind to dispersed pancreatic acini. We have also explored the abilities of various peptides to inhibit this binding, and the relationship between a peptide's ability to inhibit binding of 125I-physalaemin and its ability to alter acinar cell function. Our results indicate that pancreatic acini possess a single class of receptors that interact reversibly with physalaemin, eledoisin, and substance P and that occupation of approximately 45% of these receptors is sufficient to cause a maximal change in acinar cell function.MATERIALS AND METHODS Materials. Male guinea pigs (175-225 g) were obtained from the Small Animals Section, Veterinary Resources Branch, National Institutes of Health. Hepes and cyclic somatostatin were obtained from Calbiochem; synthetic human gastrin was from ...